PDS Biotechnology Corporation
VACCINE COMPOSITIONS AND METHODS OF USE

Last updated:

Abstract:

The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one antigen, wherein the adjuvant is a cationic lipid. The disclosure also provides methods of treating a disease in a mammal, methods of preventing a disease in a mammal, and methods of effecting antigen cross presentation to induce a humoral immune response and a cellular immune response in a mammal utilizing the vaccine compositions. Cross presentation of various antigens can be achieved by formulating the specific antigens with cationic lipids possessing adjuvant properties.

Status:
Application
Type:

Utility

Filling date:

22 Jul 2021

Issue date:

25 Nov 2021